JP1701912S - - Google Patents

Info

Publication number
JP1701912S
JP1701912S JPD2021-13264F JP2021013264F JP1701912S JP 1701912 S JP1701912 S JP 1701912S JP 2021013264 F JP2021013264 F JP 2021013264F JP 1701912 S JP1701912 S JP 1701912S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2021-13264F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of JP1701912S publication Critical patent/JP1701912S/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2021-13264F 2020-12-21 2021-06-18 Active JP1701912S (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EM83553410002 2020-12-21

Publications (1)

Publication Number Publication Date
JP1701912S true JP1701912S (enExample) 2021-12-13

Family

ID=79644374

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2021-13264F Active JP1701912S (enExample) 2020-12-21 2021-06-18

Country Status (3)

Country Link
US (2) USD989784S1 (enExample)
JP (1) JP1701912S (enExample)
CA (1) CA204307S (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD956063S1 (en) * 2020-03-18 2022-06-28 Capital One Services, Llc Display screen or portion thereof with animated card communication interface
USD1033463S1 (en) * 2020-12-21 2024-07-02 Roche Diabetes Care, Inc. Display screen or portion thereof with graphical user interface
JP1701912S (enExample) * 2020-12-21 2021-12-13
USD1039567S1 (en) * 2021-09-06 2024-08-20 Roche Diabetes Care, Inc. Display screen or portion thereof with a graphical user interface
USD1098131S1 (en) * 2022-10-24 2025-10-14 Sanofi Display screen with a graphical user interface
USD1101763S1 (en) * 2022-10-24 2025-11-11 Sanofi Display screen with a graphical user interface

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD437342S1 (en) * 1999-12-07 2001-02-06 Microsoft Corporation Type font
USD521522S1 (en) * 2004-06-24 2006-05-23 Verizon Wireless Icon for the display screen of a cellulary communicative electronic device
USD565589S1 (en) * 2005-09-09 2008-04-01 Microsoft Corporation Icon for a portion of a display screen
USD551247S1 (en) * 2005-11-14 2007-09-18 Microsoft Corporation Icon for a portion of a display screen
USD553639S1 (en) * 2005-11-14 2007-10-23 Microsoft Corporation Icon for a portion of a display screen
US20090277697A1 (en) * 2008-05-09 2009-11-12 Smart Technologies Ulc Interactive Input System And Pen Tool Therefor
USD613754S1 (en) * 2009-04-17 2010-04-13 Microsoft Corporation Icon for a display screen
DK2506914T3 (en) * 2009-11-30 2018-12-10 Hoffmann La Roche ANALYSIS MONITORING AND FLUID SUBMISSION SYSTEM
WO2012059209A1 (en) * 2010-11-01 2012-05-10 Roche Diagnostics Gmbh Fluid dispensing device with a flow detector
US9136939B2 (en) * 2011-12-29 2015-09-15 Roche Diabetes Care, Inc. Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device
USD682882S1 (en) * 2012-03-30 2013-05-21 Microsoft Corporation Display screen with icon
USD768856S1 (en) * 2015-02-05 2016-10-11 Roche Diabetes Care, Inc. Lancing device
WO2017123525A1 (en) * 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
USD826275S1 (en) * 2016-04-08 2018-08-21 King.Com Limited Display screen with icon
USD803887S1 (en) * 2016-10-31 2017-11-28 Microsoft Corporation Display screen with icon
US11083852B2 (en) * 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11116899B2 (en) * 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
USD910708S1 (en) * 2018-05-08 2021-02-16 Apple Inc. Electronic device with graphical user interface
USD914756S1 (en) * 2018-10-29 2021-03-30 Apple Inc. Electronic device with graphical user interface
JP1675966S (enExample) * 2020-04-01 2021-01-04
USD958183S1 (en) * 2020-07-30 2022-07-19 Sanofi Display panel portion with an animated computer icon
USD949195S1 (en) * 2020-07-30 2022-04-19 Sanofi Display panel portion with an animated computer icon
USD958834S1 (en) * 2020-07-30 2022-07-26 Sanofi Display panel portion with an animated computer icon
USD999239S1 (en) * 2020-10-07 2023-09-19 Waymo Llc Display screen portion with icon
JP1701912S (enExample) * 2020-12-21 2021-12-13
CA204309S (en) * 2020-12-21 2023-11-29 Hoffmann La Roche Display screen with graphical user interface
USD969843S1 (en) * 2021-02-25 2022-11-15 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
USD966304S1 (en) * 2021-02-25 2022-10-11 Rightpoint Consulting, LLC Display panel portion with an animated computer icon
CA3213005A1 (en) * 2021-04-21 2022-10-27 Abbott Diabetes Care Inc. Systems and methods for diabetes management
USD1025131S1 (en) * 2022-05-05 2024-04-30 Capital One Services, Llc Display screen with graphical user interface for card communication
USD1025130S1 (en) * 2022-05-05 2024-04-30 Capital One Services, Llc Display screen with graphical user interface for card communication
USD1026017S1 (en) * 2022-05-05 2024-05-07 Capital One Services, Llc Display screen with animated graphical user interface for card communication

Also Published As

Publication number Publication date
CA204307S (en) 2023-12-12
USD989784S1 (en) 2023-06-20
USD1046895S1 (en) 2024-10-15

Similar Documents

Publication Publication Date Title
JP1675966S (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134275A1 (es) Anticuerpos cd24
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134206A1 (es) Degradantes y usos de los mismos
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134180A1 (es) Péptidos inmunogénicos de magea1, proteínas de unión que reconocen los péptidos inmunogénicos de magea1 y usos de los mismos